A new antiviral has shown promise against the dengue virus in mice and has the potential to be used as a preventative measure.
List view / Grid view
A study has shown the mosquito protein AEG12 inhibits flaviviruses, the family of viruses that cause yellow fever, dengue and Zika.
Scientists show that an antibody targeting a protein acting as a viral toxin, can prevent the dengue virus from infecting human cells.
The global network of centers will investigate where pathogens emerge and how they adapt to cause disease in humans, in the hopes of increasing our preparedness for future disease outbreaks.
A study has shown that the COVID-19 pandemic has resulted in a high level of research donations, making the condition the third most funded disease on average by year.
Researchers are developing methos to decrease the body size and weight of mosquitoes in order to control the spread of dengue and Zika...
24 June 2016 | By Victoria White, Digital Content Producer
Scientists have identified antibodies that can efficiently neutralise both the dengue virus and the Zika virus...